Concepedia

Wakefulness Promotion

Wakefulness Promotion is a pharmacological effect characterized by the selective enhancement of alertness and sustained attention without the agitation or euphoria typically associated with classical stimulants, mediated through preferential modulation of monoaminergic and/or hypocretin neurotransmission.

36

Publications

1.7K

Citations

179

Authors

69

Institutions

Publications per year

2017–2026

11

Parents

Publications

36

The Wake-Promoting Hypocretin–Orexin Neurons Are in an Intrinsic State of Membrane Depolarization

Emmanuel Eggermann, Laurence Bayer, Mauro Serafin et al. · Journal of Neuroscience · 2003 · 172 citations · Full text

, , +17

The alerting effects of caffeine, bright light and face washing after a short daytime nap

Mitsuo Hayashi, Akiko Masuda, Tadao Hori · Clinical Neurophysiology · 2003 · 126 citations

, , +15

Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats

Éva Szentirmai, Levente Kapás, James M. Krueger · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2006 · 118 citations

, , +17

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

Thomas M. Engber, Elizabeth J. Koury, Shelley A Dennis et al. · Neuroscience Letters · 1998 · 116 citations

, , +16

<i>Drosophila</i> D1 dopamine receptor mediates caffeine-induced arousal

Rozi Andretić Waldowski, Young-Cho Kim, Frederick S. Jones et al. · Proceedings of the National Academy of Sciences · 2008 · 109 citations · Full text

, , +17

1–5 of 36

Authors

179

  1. LD
    Lisa D. Aimone

    Avalon Pharma (United States), United States

    3 publications · 58 citations

    3

    h-index

  2. KA
    Kurt A. Josef

    Brandywine Photonics (United States), United States

    2 publications · 23 citations

    2

    h-index

  3. RL
    Robert L. Hudkins

    Brandywine Photonics (United States), United States

    2 publications · 23 citations

    2

    h-index

  4. JL
    Jacquelyn Lyons

    Teva Pharmaceuticals (United States), United States

    2 publications · 23 citations

    2

    h-index

  5. TI
    Takashi Ishikawa

    Sumitomo Metal Mining (Japan), Japan

    2 publications · 122 citations

    2

    h-index

1–5 of 179

Institutions

69

  1. Beth Israel Deaconess Medical Center

    Boston, United States

    2 h-index

    4 publications

    180 citations

  2. Takeda (Japan)

    Osaka, Japan

    2 h-index

    14 publications

    990 citations

  3. Nanchang University

    Nanchang, China

    2 h-index

    13 publications

    245 citations

  4. SRI International

    Menlo Park, United States

    2 h-index

    8 publications

    156 citations

  5. First Affiliated Hospital of Nanchang University

    Nanchang, China

    2 h-index

    13 publications

    245 citations

  6. McGill University

    Montreal, Canada

    2 h-index

    1 publications

    172 citations

  7. University of Missouri

    Columbia, United States

    1 h-index

    3 publications

    177 citations

  8. The University of Texas MD Anderson Cancer Center

    Houston, United States

    1 h-index

    1 publications

    21 citations

1–8 of 69

Venues

  1. Neuropsychopharmacology

    2 publications · 81 citations

    2

    h-index

  2. eNeuro

    2 publications · 64 citations

    2

    h-index

  3. Pharmacology Biochemistry and Behavior

    2 publications · 130 citations

    2

    h-index

  4. Bioorganic & Medicinal Chemistry Letters

    2 publications · 23 citations

    2

    h-index

  5. 1

    h-index

1–5